Commercialization
BioCrossroads has stoked state's life sciences industry, but challenges remain
February 11, 2012
J.K. WallIn the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies,
an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national
reports on life sciences.
MorePurdue hopes center simplifies commercialization
January 30, 2012
J.K. WallPurdue University's new Innovation and Commercialization Center is supposed to be a one-stop shop for professors to get help
developing their research into products and for outside investors to find out what research is taking place there.
MoreInventor on quest to bring medical device to market
August 13, 2011
Chris O'MalleyLicensed practical nurse Nic Davis invented a device to kill and prevent the introduction of microorganisms that collect at
catheter ports.
MoreFirm joins race with IU autism drug
April 9, 2011
J.K. WallThe Indiana University School of Medicine has licensed a pediatric psychiatrist's patent on
an alcohol-dependency drug that the doctor discovered improves the language and social skills of autism patients. IU has licensed
the patent to Indianapolis-based Confluence Pharmaceuticals Inc.
MoreWishard gives IT firms in health and life sciences a place to test products
April 9, 2011
Chris O'MalleyTechPoint-led initiative is meant to help bring inventions to market by giving them a trial in real-world setting.
MoreMarcadia Biotech principals ponder next course
March 22, 2011
Chris O'MalleyMarcadia execs French, Hawryluk reflect on massive growth of Carmel firm after sale to Roche.
MoreBall State seeks leader to implement Innovation Corp. plan
March 5, 2011
Chris O'MalleyBall State University is conducting a nationwide search for a president to lead a not-for-profit it launched to boost the
commercialization of the university’s intellectual property.
MoreLife sciences to drive Purdue's next decade of building
January 26, 2011
J.K. WallOver the past 10 years, Purdue University has built Discovery Park into a thriving research and business incubation center,
launching more than 30 companies and hosting dozens more. Now Purdue will spend more than $164 million to construct a Life
and Health Sciences Quadrangle next to Discovery Park.
MoreFormer IU tech-transfer chief: State isn't competitive enough
October 30, 2010
Norm HeikensMark Long was president of the Indiana University Research & Technology Corp., which was responsible for the university’s
tech transfer, before launching a consulting firm, Long Performance Advisors, in 2008.
MoreIU hits license jackpot; Purdue royalties surge
September 18, 2010
Chris O'MalleyIndiana University had a license or two to print money from the commercialization of its technology over the last year—and
did it ever. While Purdue University didn’t collect as much in royalties from commercialization, it pulled down record
levels of research grants.
MorePromising ethanol yeast nears market launch
June 19, 2010
Chris O'MalleyA firm that may have developed a breakthrough yeast for ethanol production has landed new investment and high-octane board
members. Two-year-old Xylogenics Inc. also says it plans to license its first bioengineered yeast later this year.
MoreIndiana Seed Fund nearing end of $6 million stash
June 5, 2010
Chris O'MalleyHaving invested in 10 companies since 2005 and with its $6 million pot of money running low, the Indiana Seed Fund is nearing
a crossroads.
MoreCancer researcher battling Semafore in court
May 29, 2010
Chris O'MalleyFormer collaborator alleges firm breached its agreement with him and refused to pay royalty income.
MoreIU targets tech-transfer gap
May 15, 2010
Kathleen McLaughlinIndiana University is showing signs that it's finally serious about translating research into commercial product, through
grants it is awarding via its $10 million Innovate Indiana Fund and by developing a computing technology mini-campus.
MoreChao exit hurts drug development industry
April 28, 2010
J.K. WallPurdue University’s decision to close the Chao Center in West Lafayette is a setback for Indiana’s effort to grow
a vibrant contract drug manufacturing sector. But it’s just the latest in a series of unexpected changes—not all
for
the worse—since Indianapolis-based BioCrossroads launched a contract drug manufacturing initiative in late 2007.
MoreMedical device startup FlowCo enlists Guidant alums
April 24, 2010
Chris O'MalleyThe upstart developer of a device to help doctors choose the right-sized stent to prop open clog-prone arteries has brought
aboard former Guidant Corp. executives, including Bill McConnell. Their regulatory and marketing expertise could help FlowCo
Inc. bring its artery-measurement
product to market as soon as 2011.
MoreAriad loses $65M patent appeal against Eli Lilly
March 22, 2010
Bloomberg NewsMonday's decision throws out a $65.2 million patent-infringement verdict won by Ariad for royalties on Lilly's osteoporosis
drug Evista and sepsis medicine Xigris.
MoreVortek Surgical moving HQ to Brownsburg, adding 60 jobs
February 18, 2010
IBJ StaffIndianapolis-based Vortek Surgical LLC will relocate to Brownsburg, expanding its headquarters, manufacturing and distribution
operations and creating more than 60 jobs in the next three years.
MoreHealth firms still attracting venture capital
February 3, 2010
J.K. WallThe uncertainty of health care reform and a bad economy curtailed venture capital flow in 2009. That trend hit Indianapolis,
but the rest of the state actually saw an increase.
MoreEntrepreneur says quality of venture capital as important as quantity
January 2, 2010
IBJ StaffJim Pearson knows a thing or two about raising money from venture capitalists. And he has some advice for BioCrossroads:
Teach entrepreneurs the value of money.
MoreCompany's medical device earns expedited review
December 9, 2009
FAST Diagnostics LLC said initial human trials on its method to measure kidney function faster and more accurately than existing
techniques could begin as early as next year, with commercialization following by 2012.
MoreAarden Pharmaceuticals chose Indianapolis over San Diego for headquarters
November 14, 2009
IBJ StaffThanks partly to a state grant and support from Indiana’s BioCrossroads life sciences initiative, principals “decided
locating here would give Aarden a better chance of success.
MoreTechPoint to focus on IT firms specializing in medical, life sciences sectors
October 31, 2009
Chris O'MalleyLong tracking the emergence of information technology firms involved in the health and life sciences sector, the state’s
IT trade group, TechPoint, is undergoing a mitosis of sorts to help fuel the trend. It has created Advancing
Life Science & Health Care Information Technology, or ALHIT, which will focus on growing this subset of the IT realm.
MoreMedical device developer receives $1M in federal funding
September 10, 2009
Scott OlsonIndianapolis-based FAST Diagnostics, a developer of a method to quickly measure kidney function, announced today that it has
received $1 million in federal funding.
MoreTenants trickling in to Purdue’s technology center
August 17, 2009
Chris O'MalleyFor a city feverishly growing its technology and life sciences sectors, it seemed a bit anticlimactic last January when
Purdue University dedicated its new technology center with only one tenant. But the lone tenant in the $12.8
million complex, FlamencoNets, a high-tech telecommunications firm, is about to get some company.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
IBJ Featured Advertisers
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
graham. they are even better w/ roasted marshmallows and melted chocolate
Apparently ticket sales are slow too...mas emails have been sent by the speedway in a last ditch attempt to get place fans to come.
Garden Valley Veggie flavor Wheat Thins Toasted Chips. Don't judge until you try them, haters!
Doc, a few important errors in your statements:
(1) The developer is spending the CITY'S money (the city is paying for the cost of the garage), so the city can damn well insist on a quality design.
(2) The LAW requires the proposed building to comply with design standards, and insisting that people follow the law is not giving anyone the "run-around."
(3) A two-week delay to make some minimal aesthetic improvements is hardly a great imposition being imposed on the developer.
(4) If the developer would rather build a crappy building elsewhere with their own money, then they are welcome to pick up and do so.
(4) Indianapolis is a major city, not some podunk town that needs to spread its legs for any developer that throws the place a sideways glance. Indianapolis should insist on the best, not settle for junk. Accepting anything is not going to make Indianapolis grow any faster (not sure where you got that silly notion from), nor is Indianapolis a slow-growth city compared to similarly sized city's in the Midwest.
Alone. Or with cheese.